Quest Diagnostics Company Insiders

Quest Diagnostics' latest congressional trading

Quest Diagnostics Management Team Effectiveness

The company has Return on Asset of 0.0612 % which means that on every $100 spent on assets, it made $0.0612 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1435 %, implying that it generated $0.1435 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.10 in 2026, whereas Return On Tangible Assets are likely to drop 0.14 in 2026. At this time, Quest Diagnostics' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 16.6 B in 2026, whereas Non Currrent Assets Other are likely to drop slightly above 179.6 M in 2026. Common Stock Shares Outstanding is likely to rise to about 126.7 M in 2026, whereas Net Income Applicable To Common Shares is likely to drop slightly above 773.7 M in 2026. Quest Diagnostics owns a total of 111.24 Million outstanding shares. The majority of Quest Diagnostics Incorporated outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Quest Diagnostics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Quest Diagnostics. Please pay attention to any change in the institutional holdings of Quest Diagnostics as this could imply that something significant has changed or is about to change at the company. Please note that on December 12, 2025, Representative Julie Johnson of US Congress acquired under $15k worth of Quest Diagnostics's common stock. Some institutional investors establish a significant position in stocks such as Quest Diagnostics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Quest Diagnostics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Quest Diagnostics Workforce Comparison

Quest Diagnostics Profit Margins

The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.15 %, which entails that for every 100 dollars of revenue, it generated $0.15 of operating income.

Quest Diagnostics Insider Trading History

Quest Diagnostics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Quest Diagnostics often depends on how effective the management is. Quest Diagnostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Quest management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Quest management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Quest Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Quest Diagnostics Incorporated. Check Quest Diagnostics' Beneish M Score to see the likelihood of Quest Diagnostics' management manipulating its earnings.

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.